Position in EXEL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$56,423
+$10,960 QoQ
Shares Held
1,037
-2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#615
of 751 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026V-Square Quantitative Management LLC holds $6,143,388 across 14 Biotechnology names. EXEL ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,531 | $2,747,413 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,211 | $665,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,025 | $639,128 | |
| 4 | INCY |
Incyte Corp
|
5,417 | $614,071 | |
| 5 | MRNA |
Moderna, Inc.
|
6,532 | $457,435 | |
| 6 | TECH |
BIO-TECHNE Corp
|
6,197 | $437,818 | |
| 7 | RPRX |
Royalty Pharma plc
|
6,318 | $354,250 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
1,037 | $56,423 |
All Filings in EXEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,423 | 1,037 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $45,463 | 1,060 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $44,180 | 1,008 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $32,663 | 741 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $57,705 | 1,563 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $52,047 | 1,563 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $29,531 | 1,138 | Shares | Sole | 2024-10-17 | |
| 2023-06-30 | $9,363 | 490 | Shares | Sole | 2023-07-26 | |
| No filing history on record for this holder in this stock. | ||||||